BriefTea
Every story in sixty words
Get the free app no ads · no paywallExplained in plain English
This study is a big step towards preventing Alzheimer's before memory problems even start. By looking for specific markers in the blood, researchers hope to identify people at high risk and intervene with treatments like Trontinemab. This approach could change how we tackle dementia, moving from treating symptoms to proactive prevention.
Stories that explain this
NHS begins testing a new Alzheimer's drug on adults without memory problemsRelated explainers
Why test healthy adults? What is Trontinemab? How can AI stop contrails? What is Alzheimer's? What is Alzheimer's disease? What is the Alzheimer's Society? Who is the Alzheimer's Society? Why announce so early?The full catalogue
Browse every card filed under W →We would like to count visits and see which links bring readers here. That means storing a random ID in your browser. No cookies, no ads, no profile. How it works.